12:00 AM
Nov 18, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

GKT137831: Phase II started

Genkyotex began a double-blind, placebo-controlled, international Phase II trial to evaluate GKT137831in 120 patients with Type II diabetes and residual albuminuria despite maximal inhibition of...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >